JONATHAN SLONIN
CIK 1875723 · Chief Medical Officer · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.34M
Companies
1
Total Filings
29
Lifetime Open-Market Net
-$557.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PCRX | Chief Medical Officer | 218,912 | $24.38 | $5.34M | -$557.4K | 21 | 2026-06-05 |
Recent Filings · Page 2 of 3
29 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-04 | PCRX | Grant (A) | +93,600 | $0 | EDGAR |
| 2025-01-06 | PCRX | Notice (144) | −879 | -$16.2K | EDGAR |
| 2025-01-06 | PCRX | Mixed | −1,250 | -$23.0K | EDGAR |
| 2024-08-02 | PCRX | Notice (144) | −945 | -$18.9K | EDGAR |
| 2024-08-02 | PCRX | Mixed | −1,250 | -$25.3K | EDGAR |
| 2024-07-03 | PCRX | Mixed | −3,312 | -$95.5K | EDGAR |
| 2024-07-02 | PCRX | Notice (144) | −2,836 | -$80.1K | EDGAR |
| 2024-06-13 | PCRX | Mixed | +49,288 | -$143.2K | EDGAR |
| 2024-06-11 | PCRX | Notice (144) | −5,012 | -$143.2K | EDGAR |
| 2024-06-05 | PCRX | Tax (F) | −1,615 | -$49.9K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.